psychiatry research case reports indexing

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Publications
Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

Advanced Search
Journal List
J Med Case Rep

How to choose the best journal for your case report

Richard a. rison.

1 University of Southern California Keck School of Medicine, Los Angeles County Medical Center, 12401 Washington Blvd., Whittier, CA 90602 USA

2 PIH Health Hospital-Whittier Stroke Center, PIH Health Hospital Non-Invasive Vascular Laboratory, 12401 Washington Blvd., Whittier, CA 90602 USA

Jennifer Kelly Shepphird

3 JKS Science & Medical Writing, Los Angeles, CA USA

Michael R. Kidd

4 Faculty of Medicine, Nursing and Health Sciences, Flinders University, GPO Box 2100, Adelaide, SA 5001 Australia

5 Department of Family & Community Medicine, University of Toronto, 500 University Avenue, Toronto, M5G 1V7 Canada

Since the establishment of the Journal of Medical Case Reports in 2006, the number of journals that publish case reports has increased rapidly, and most of these journals are open access. Open access publishing usually requires authors to pay publication fees while offering the articles online, free of charge, and free of most copyright and licensing restrictions. The movement for open access has gained support in the research community, with the publishers BioMed Central and PLOS ONE becoming leaders in scientific publishing in their number of articles and citations. As the number of open access publishers has exploded, so too has the number of publishers that act in bad faith to profit from the open access model. Simple guidelines have been developed and resources are available to help authors choose a suitable journal for publication of their case reports.

Case reports offer unique value to the body of medical knowledge by describing new diseases, disease mechanisms, therapeutic approaches, and adverse or beneficial effects of drugs. The act of recording, discussing with colleagues, and publishing clinical observations as case reports remains essential to the art of medicine and patient care [ 1 ]. These short communications generate or enforce hypotheses that may lead to further evaluation in larger study designs [ 2 ]. In providing detailed descriptions of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient, case reports reflect clinical experience and support medical progress. By design, the format lacks statistical sampling, placing it at the bottom of the hierarchy of clinical evidence. Case reports do not include controls, have limited sample size (one to a few individuals), and are unblinded, limitations that require a cautious approach to interpretation of findings. General medical journals publish case reports sparingly, often only publishing those that provide new information on adverse events that can be linked to an intervention [ 3 , 4 ]. Journal editors may limit inclusion of case reports because they are cited less often than meta-analyses and randomized controlled trials, which negatively affects a journal’s impact factor.

The merits of large randomized studies are well known, but many clinicians recognize the value of case reports as a complement to evidence-based medicine. The case-based nature of clinical practice often is at odds with the population-based nature of research studies, where the findings may have little relevance to an individual patient. Narrow inclusion criteria and the absence of co-morbidities in randomized trials often create a disconnection between typical patient populations and populations represented in research studies [ 3 ]. Case reports provide enough detail on one or a small number of patients for clinicians to relate to their own practice. They are educational and interesting to read. For the challenging and patient-centered task of reporting on individual cases with inherent heterogeneous human variability in clinical research and the goal of applicability to real-life circumstances, the CARE guidelines provide a framework for completeness and transparency in case reports. The guidelines aid in finding the balance between adequate detail and concise writing [ 5 ].

In response to renewed interest and acknowledgment of their value, the number of peer-reviewed journals that publish case reports has increased in recent years to more than 160 [ 6 ]. In the digital era of paperless journals with few space restrictions, the case report has seen a resurgence. The digital format facilitates searches, which is a key factor in their utility [ 7 ]. Most of the case report journals are open access and have high acceptance rates. As the number of new scientific journals increases, so do the number of questionable publishers that mislead researchers regarding fees, peer review, and academic credentials. The process of submitting scientific work for publication now includes the need for thorough vetting of potential publishers.

New case report journals

In line with the growing demand for case report publishing opportunities, the number of new peer-reviewed journals that focus on case reports had increased to more than 160 journals produced by 78 publishers by mid-2015. Figure 1 shows that the number of case report journals increased rapidly beginning in 2007, a timeframe that coincides with the Great Recession of the late 2000s and the concomitant decline in federal and other funding for basic science and other research. Some of the new journals cover general medicine and others cover specific therapeutic areas. Most case report journals (94%) are open access and approximately 40% are indexed in PubMed. Clinical issues covered by case report journals include previously unreported adverse effects of drugs or other treatments, unexpected events that occur in the course of observing or treating a patient, observations on disease pathogenesis, presentations and/or management of new and emerging diseases, new therapeutic approaches, ethical challenges in patient management, and strategies for preventing or overcoming medical errors [ 6 , 8 ].

An external file that holds a picture, illustration, etc.
Object name is 13256_2017_1351_Fig1_HTML.jpg

Number of case report journals by year. The number of journals that publish case reports has increased rapidly since 2007. (Reprinted with permission from Akers [ 6 ])

Open access publishing offers freely available and unrestricted use of research and scholarship, which many researchers see as vital to efficient dissemination of science in the digital world [ 9 ]. The open access model usually requires authors to pay submission and publication fees upon acceptance, typically between US $300 and $1200 [ 6 ]. The move toward making scholarly publications more accessible through open access has continued to gain supporters among the research community. The open access publisher BioMed Central launched in 2000 with 231 articles published that year in 60 journals. In 2015, the numbers increased to more than 30,000 articles in over 290 journals. In 2014, BioMed Central articles were accessed more than 277 million times and had 426,000 citations [ 10 ]. Similarly, the number of publications from the open access publisher PLOS ONE, increased from 138 at its inception in 2006 to 28,107 in 2015 [ 11 ].

Case report journals

Reprinted with permission from Akers [ 6 ]

Controversial journals and publishers

As scientific publishing shifts from a business model of subscription revenue to open access, the number of open access journals has exploded. However, the proliferation of journals that will publish seemingly anything for a fee has caused alarm among many in the global research community. Alongside many respected open access publishers, others have entered the space acting in bad faith. Some see it as the “dark side” of open access, a growing collection of pseudo-academic, prestigiously titled journals, many of which have similar but not quite identical websites and names to those of well-known established journals. Many of the websites look sufficiently impressive that non-experts doing online research have trouble distinguishing credible research from junk. Experienced academics have been misled into submitting manuscripts and even serving on editorial boards for pseudo-academic journals, agreements that often are difficult to undo. Most of these journals do not post their publication fees, and often authors are not informed of fees until after submitting a manuscript. Withdrawal of a manuscript, which is necessary before submitting the same paper to a legitimate journal, may require payment of the high fees first [ 12 ]. For some authors, this means their work may be lost essentially to the disreputable publisher. Many researchers have complained about poorly executed or absent peer review, hidden fees for submission and publication, and unapproved inclusion of researchers’ names on editorial boards.

Jeffrey Beall, a librarian and associate professor at Auraria Library at the University of Colorado, Denver, coined the term “predatory open access publishing” to describe this situation. He is a critic of open access publishing, blaming the system for creating the problem of predatory publishers. His blog Scholarly Open Access, although removed by Beall for unknown reasons in January 2017, closely monitored the increasing number of open access publishers and alerted readers to individuals, publishers, publications, meetings, and scholarly metrics that, in the view of Mr Beall, appeared to exploit the open access model [ 13 ]. He maintained a list of “potential, possible, or probable predatory scholarly open-access publishers” and another list of standalone journals. His criteria for inclusion on the lists were derived from the Code of Conduct for Journal Publishers from the Committee on Publication Ethics (COPE), and Principles of Transparency and Best Practice in Scholarly Publishing from COPE, the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors [ 14 – 16 ]. Similarly, information in these communications may help authors to discern whether they can trust a particular publisher or journal. The Federal Trade Commission (FTC) in the USA has taken notice of questionable publication practices. In August 2016 it filed a suit against the OMICS Group, a global conglomerate based in India that publishes more than 700 open access journals. The suit claimed that the OMICS Group misled researchers, particularly with regard to their peer-review process (or lack thereof) and high fees that were not readily apparent to authors upon manuscript submission [ 17 ]. The purpose of the lawsuit, according to the FTC, is to better inform authors of publishing fees and to have a more transparent peer-review system [ 18 ]. The case is still to be litigated in federal court in Nevada at the time of writing this article.

The challenge for watchdogs and authors alike is to decide when a publisher is untrustworthy or simply unprofessional. Some publishers may fall under suspicion due to poor copy editing or amateurish website design, but this may not reflect an outright neglect of scholarly standards. It is important not to blacklist startup publishers who lack experience. Another problem with maintaining lists of disreputable publishers is that because copycat journals are often short-lived, the blacklist will continue to grow but individual entries may quickly become obsolete.

Choose the right journal: Think. Check. Submit.

The “Think. Check. Submit.” campaign arose in response to concerns about publishing practices, and the effort is supported by a coalition of scholarly publishing organizations. “Think. Check. Submit.” takes a positive approach to help researchers identify credible journals, providing up-to-date guidance for choosing where to publish [ 18 , 19 ]. To ascertain whether a journal is trusted, authors are advised to follow this checklist:

Have you read any articles in the journal before?
Is it easy to discover the latest papers in the journal?
Is the publisher name clearly displayed on the journal website?
Can you contact the publisher by telephone, email, and post?
Does the journal site explain what these fees are for and when they will be charged?
Have you heard of the editorial board members?
Do members of the editorial board mention the journal on their own websites?
Do they belong to the COPE?
If the journal is open access, is it listed in the Directory of Open Access Journals (DOAJ)?
If the journal is open access, does the publisher belong to the OASPA?
Is the publisher a member of another trade association?

In addition to consulting colleagues and academic librarians for journal suggestions, authors have available to them several online resources. BioMed Central previously collaborated with Edanz, a company that assists authors in navigating the publication process, to create the author academy [ 10 ]. The free online guide describes best practices in writing and publishing a manuscript, including sections on choosing a journal, writing the manuscript, and publication ethics, among others. BioMed Central now contracts with Nature Research Editing Services and American Journal Experts, both of which offer similar services [ 20 , 21 ].

Several automated search tools help identify suitable journals as well. Authors insert keywords from their manuscript abstract into a search engine, which then compares the words to many online publications and Edanz Journal Selector covers a broad range of journals. The online tool is free, and Edanz also offers a journal selection service (US $300) in which experts use their publication experience to identify up to four of the best journals for a given paper [ 22 ]. The Journal/Author Name Estimator (Jane) focuses on biomedical science journals by searching the Medline database published by the US National Library of Medicine [ 23 ]. Other online services offered by publishers Springer and Elsevier suggest journals from their own extensive catalogues [ 24 , 25 ].

Impact factor

Journal impact factors, calculated and published by Thomson Reuters, measure the average number of citations per published article for papers published over a 2-year period. Despite the fact that the simple metric can be misleading, the impact factor has become, over time, a marker of journal prestige and desirability. The judgment of a paper’s value is often based more on the journal in which it appears than on its content. Many researchers contend that reliance on impact factors undervalues disciplines or study designs, such as case reports, which have lower citation rates. Overall, the number of citations of an article is commensurate with hierarchies of evidence, with meta-analyses receiving more citations than any other study design. Case reports typically receive few citations, although there are notable exceptions [ 26 ]. The number of citations of an article, however, does not necessarily reflect how widely the article has been read or the dissemination of the findings in mainstream media [ 27 ].

Efforts to embrace a broader view of value in scientific communication, and perhaps diminish the influence of impact factors, have emerged. Journals of the American Society for Microbiology (ASM) no longer advertise impact factors on their websites. Similarly, in recognizing that impact factors are just one of a number of metrics, Nature journals list a suite of citation-based metrics. Only one case report journal, Taylor & Francis’s Neurocase , has received an impact factor (1.124), dating back to 1998.

Medicine/National Institutes of Health Indexed research databases are often curated to ensure the quality of included publications. Clarivate Analytics (formerly Thomson Reuters) offers The Web of Science™, as one such example, and recently introduced the “Emerging Sources Citation Index” to complement their more selective indexes. This collection reflects the growing number of peer-reviewed publications of regional importance and in emerging fields [ 28 ].

In conclusion, the growth in number of case report journals has provided authors multiple avenues for publication but, at the same time, it has introduced a new level of uncertainty in the journal selection process. Factors to consider when choosing a journal are: the topics the journal covers, the target audience, length restrictions, and the time to publication. Open access publications, such as the Journal of Medical Case Reports from BioMed Central, offer high visibility, relatively rapid publication, and transparent publication policies. The reputation of the journal plays an increasingly important part of the decision, requiring thorough vetting of potential journals.

Acknowledgements

We thank the reviewers for their insightful and helpful comments on our editorial.

Authors’ contributions

All authors read and approved the final manuscript.

Competing interests

RAR is a Deputy Editor and MRK is the Editor-in-Chief of Journal of Medical Case Reports . JKS has nothing to disclose.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Richard A. Rison, Email: ude.csu@nosir .

Jennifer Kelly Shepphird, Email: moc.gnitirwskj@nej .

Michael R. Kidd, Email: [email protected] .

Case report

Case reports submitted to BMC Psychiatry should make a contribution to medical knowledge and must have educational value or highlight the need for a change in clinical practice or diagnostic/prognostic approaches. We will not consider reports on topics that have already been well characterised or where other, similar, cases have already been published.

BMC Psychiatry will not consider case reports describing preventive or therapeutic interventions, as these generally require stronger evidence.

BMC Psychiatry welcomes well-described and novel reports of cases that include the following: • Unreported or unusual side effects or adverse interactions involving medications. • Unexpected or unusual presentations of a disease. • New associations or variations in disease processes. • Presentations, diagnoses and/or management of new and emerging diseases. • An unexpected association between diseases or symptoms. • An unexpected event in the course of observing or treating a patient. • Findings that shed new light on the possible pathogenesis of a disease or an adverse effect.

Authors must describe how the case report is rare or unusual as well as its educational and/or scientific merits in the covering letter that will accompany the submission of the manuscript. Case report submissions will be assessed by the Editors and will be sent for peer review if considered appropriate for the journal.

Case reports should include relevant positive and negative findings from history, examination and investigation, and can include clinical photographs, provided these are accompanied by a statement that written consent to publish was obtained from the patient(s). Case reports should include an up-to-date review of all previous cases in the field. Authors should follow the CARE guidelines and the CARE checklist should be provided as an additional file.

Authors should seek written and signed consent to publish the information from the patient(s) or their guardian(s) prior to submission. The submitted manuscript must include a statement that this consent was obtained in the consent to publish section as detailed in our editorial policies .

BMC Psychiatry strongly supports open research, including transparency and openness in reporting. Further details of our Data availability policy can be found on the journal's About page.

Professionally produced Visual Abstracts BMC Psychiatry will consider visual abstracts. As an author submitting to the journal, you may wish to make use of services provided at Springer Nature for high quality and affordable visual abstracts where you are entitled to a 20% discount. Click here to find out more about the service, and your discount will be automatically be applied when using this link.

Preparing your manuscript

The information below details the section headings that you should include in your manuscript and what information should be within each section.

Please note that your manuscript must include a 'Declarations' section including all of the subheadings (please see below for more information).

Title page

The title page should:

"A versus B in the treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is the impact of factor X on subject Y: A systematic review, A case report etc."
or, for non-clinical or non-research studies: a description of what the article reports
if a collaboration group should be listed as an author, please list the Group name as an author. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section in accordance with the instructions below
Large Language Models (LLMs), such as ChatGPT , do not currently satisfy our authorship criteria . Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript
indicate the corresponding author

The Abstract should not exceed 350 words. Please minimize the use of abbreviations and do not cite references in the abstract. The abstract must include the following separate sections:

Background: why the case should be reported and its novelty
Case presentation: a brief description of the patient’s clinical and demographic details, the diagnosis, any interventions and the outcomes
Conclusions: a brief summary of the clinical impact or potential implications of the case report

Keywords

Three to ten keywords representing the main content of the article.

The Background section should explain the background to the case report or study, its aims, a summary of the existing literature.

Case presentation

This section should include a description of the patient’s relevant demographic details, medical history, symptoms and signs, treatment or intervention, outcomes and any other significant details.

Discussion and Conclusions

This should discuss the relevant existing literature and should state clearly the main conclusions, including an explanation of their relevance or importance to the field.

List of abbreviations

If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.

Declarations

All manuscripts must contain the following sections under the heading 'Declarations':

Ethics approval and consent to participate

Consent for publication, availability of data and materials, competing interests, authors' contributions, acknowledgements.

Authors' information (optional)

Please see below for details on the information to be included in these sections.

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.

Manuscripts reporting studies involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)
include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

Studies involving animals must include a statement on ethics approval and for experimental studies involving client-owned animals, authors must also include a statement on informed consent from the client or owner.

See our editorial policies for more information.

If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

If your manuscript contains any individual person’s data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

You can use your institutional consent form or our consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).

See our editorial policies for more information on consent for publication.

If your manuscript does not contain data from any individual person, please state “Not applicable” in this section.

All manuscripts must include an ‘Availability of data and materials’ statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.

Authors are also encouraged to preserve search strings on searchRxiv https://searchrxiv.org/ , an archive to support researchers to report, store and share their searches consistently and to enable them to review and re-use existing searches. searchRxiv enables researchers to obtain a digital object identifier (DOI) for their search, allowing it to be cited.

Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):

The datasets generated and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
All data generated or analysed during this study are included in this published article [and its supplementary information files].
The datasets generated and/or analysed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].
Not applicable. If your manuscript does not contain any data, please state 'Not applicable' in this section.

More examples of template data availability statements, which include examples of openly available and restricted access datasets, are available here .

BioMed Central strongly encourages the citation of any publicly available data on which the conclusions of the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs. For example:

Hao Z, AghaKouchak A, Nakhjiri N, Farahmand A. Global integrated drought monitoring and prediction system (GIDMaPS) data sets. figshare. 2014. http://dx.doi.org/10.6084/m9.figshare.853801

With the corresponding text in the Availability of data and materials statement:

The datasets generated during and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]. [Reference number]

If you wish to co-submit a data note describing your data to be published in BMC Research Notes , you can do so by visiting our submission portal . Data notes support open data and help authors to comply with funder policies on data sharing. Co-published data notes will be linked to the research article the data support ( example ).

All financial and non-financial competing interests must be declared in this section.

See our editorial policies for a full explanation of competing interests. If you are unsure whether you or any of your co-authors have a competing interest please contact the editorial office.

Please use the authors initials to refer to each authors' competing interests in this section.

If you do not have any competing interests, please state "The authors declare that they have no competing interests" in this section.

All sources of funding for the research reported should be declared. If the funder has a specific role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript, this should be declared.

The individual contributions of authors to the manuscript should be specified in this section. Guidance and criteria for authorship can be found in our editorial policies .

Please use initials to refer to each author's contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the hematological disease and the transplant. RH performed the histological examination of the kidney, and was a major contributor in writing the manuscript. All authors read and approved the final manuscript."

Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.

Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.

See our editorial policies for a full explanation of acknowledgements and authorship criteria.

If you do not have anyone to acknowledge, please write "Not applicable" in this section.

Group authorship (for manuscripts involving a collaboration group): if you would like the names of the individual members of a collaboration Group to be searchable through their individual PubMed records, please ensure that the title of the collaboration Group is included on the title page and in the submission system and also include collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country information for each author if you wish, but this should be consistent across all authors.

Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information.

Authors' information

This section is optional.

You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.

Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.

Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.

Always use footnotes instead of endnotes.

Examples of the Vancouver reference style are shown below.

See our editorial policies for author guidance on good citation practice

Web links and URLs: All web links and URLs, including links to the authors' own websites, should be given a reference number and included in the reference list rather than within the text of the manuscript. They should be provided in full, including both the title of the site and the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology Database. http://tumor.informatics.jax.org/mtbwi/index.do . Accessed 20 May 2013. If an author or group of authors can clearly be associated with a web link, such as for weblogs, then they should be included in the reference.

Example reference style:

Article within a journal

Smith JJ. The world of science. Am J Sci. 1999;36:234-5.

Article within a journal (no page numbers)

Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, et al. Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition. BMC Medicine. 2013;11:63.

Article within a journal by DOI

Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. Dig J Mol Med. 2000; doi:10.1007/s801090000086.

Article within a journal supplement

Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan. Blood 1979;59 Suppl 1:26-32.

Book chapter, or an article within a book

Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p. 251-306.

OnlineFirst chapter in a series (without a volume designation but with a DOI)

Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108.

Complete book, authored

Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.

Online document

Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.

Online database

Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. http://www.healthwise.org. Accessed 21 Sept 1998.

Supplementary material/private homepage

Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. Accessed 22 Feb 2000.

University site

Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25 Dec 1999.

Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 Nov 1999.

Organization site

ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 Feb 2007.

Dataset with persistent identifier

Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from sweet and grain sorghum (Sorghum bicolor). GigaScience Database. 2011. http://dx.doi.org/10.5524/100012 .

Figures, tables and additional files

See General formatting guidelines for information on how to format figures, tables and additional files.

Submit manuscript

Important information

Editorial board

For authors

For editorial board members

For reviewers

Manuscript editing services

Annual Journal Metrics

2022 Citation Impact 4.4 - 2-year Impact Factor 4.9 - 5-year Impact Factor 1.535 - SNIP (Source Normalized Impact per Paper) 1.291 - SJR (SCImago Journal Rank)

2023 Speed 31 days submission to first editorial decision for all manuscripts (Median) 146 days submission to accept (Median)

2023 Usage 8,228,380 downloads 7,538 Altmetric mentions

More about our metrics

Peer-review Terminology

The following summary describes the peer review process for this journal:

Identity transparency: Single anonymized

Reviewer interacts with: Editor

Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

More information is available here

BMC Psychiatry

ISSN: 1471-244X

Submission enquiries: [email protected]
General enquiries: [email protected]

Log in using your username and password

Search More Search for this keyword Advanced search
Latest content
Global health
BMJ Journals More You are viewing from: Google Indexer

Subacute sclerosing panencephalitis presenting as severe depression in an adult Vijayakumar Karthik , Kiren George Koshy , Arsha Asok , Selvarajan Chettiar BMJ Case Reports CP May 2024, 17 (5) e259111; DOI: 10.1136/bcr-2023-259111
Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis Saehyeon Kim , Kohei Horiuchi , Takehiro Ueda , Shuken Boku BMJ Case Reports CP Feb 2024, 17 (2) e258460; DOI: 10.1136/bcr-2023-258460
Fahr’s disease in a patient with recurrent pneumonias, parkinsonism and dementia Christopher Jude Pinto , Harshita Agrawal , Holly Schmidt , Layth Tumah BMJ Case Reports CP Jan 2024, 17 (1) e258470; DOI: 10.1136/bcr-2023-258470
Neuropsychiatric disorder with basal ganglia lesions Prashant Bhatele , Arunmozhimaran Elavarasi , Ajay Garg BMJ Case Reports CP Jan 2022, 15 (1) e245482; DOI: 10.1136/bcr-2021-245482
Efficacious retrial of electroconvulsive therapy for major depressive disorder after a prolonged seizure in an older adult Joseph Kramkowski , Swapnil Rath BMJ Case Reports CP May 2023, 16 (5) e247633; DOI: 10.1136/bcr-2021-247633
Rapid ping-pong eye deviation following a recovery from carbon dioxide narcosis Shuichiro Neshige , Ohno Narumi , Shiro Aoki , Hirofumi Maruyama BMJ Case Reports CP Mar 2021, 14 (3) e241740; DOI: 10.1136/bcr-2021-241740
Transient depersonalisation/derealisation syndrome from tramadol Suthimon Thumtecho , Sorawit Wainipitapong , Polpat Tantakitti BMJ Case Reports CP Jun 2023, 16 (6) e254909; DOI: 10.1136/bcr-2023-254909
Chronic histiocytic intervillositis (CHI): an under-recognised condition with potential serious sequelae in pregnancy Ai Xin Lee , Brian Run Yi Tan , Chye Lee Kho , Kim Teng Tan BMJ Case Reports CP Apr 2021, 14 (4) e241637; DOI: 10.1136/bcr-2021-241637
Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis H Swarna Rekha , Sabharisan Paramasivam , Kalaiarasi Raja , Balaji Bharadwaj BMJ Case Reports CP Oct 2023, 16 (10) e254790; DOI: 10.1136/bcr-2023-254790
Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy Geert Schurgers , Baer M G Arts , Alida A Postma , Anna de Kort BMJ Case Reports CP Feb 2021, 14 (2) e238922; DOI: 10.1136/bcr-2020-238922
Anaesthesia (209)
Cardiovascular medicine (985)
Complementary medicine (6)
Dentistry and oral medicine (213)
Dermatology (539)
Clinical diagnostic tests (50)
Radiology (diagnostics) (146)
Surgical diagnostic tests (23)
Diagnostics
Drugs and medicines (1781)
Ear, nose and throat/otolaryngology (454)
Disaster response
Poisoning (49)
Resuscitation (57)
Trauma (160)
Emergency medicine (475)
Adrenal disorders (118)
Calcium and bone (97)
Diabetes (127)
Drugs: endocrine system (25)
Lipid disorders (26)
Metabolic disorders (89)
Pituitary disorders (57)
Thyroid disease (118)
Endocrinology (652)
Changing physician behavior
Effectiveness of care
Gastroenterology (914)
Drugs: gastrointestinal system (44)
Endoscopy (165)
GI bleeding (99)
Infection (gastroenterology) (107)
Inflammatory bowel disease (72)
Liver disease (186)
Neurogastroenterology
Oesophagus (55)
Pancreas and biliary tract (100)
Pancreatitis (61)
Portal hypertension (16)
Small intestine (76)
Stomach and duodenum (85)
General practice / family medicine (242)
Clinical genetics
Cytogenetics
Genetic screening / counselling (92)
Molecular genetics
Genetics (291)
Elder abuse
End of life decisions (geriatric medicine) (2)
Long term care (18)
Psychogeriatrics
Geriatric medicine (65)
Haematology (incl blood transfusion) (531)
HIV/AIDS (80)
Immunology (including allergy) (56)
Infectious diseases (1322)
Adult intensive care (301)
Mechanical ventilation (19)
Neonatal intensive care (90)
Paediatric intensive care (69)
Intensive care (560)
Brain stem / cerebellum (85)
Cerebral palsy (6)
Clinical neurophysiology (40)
Coma and raised intracranial pressure (29)
Cranial nerves (107)
Dementia (7)
Drugs: CNS (not psychiatric) (33)
Epilepsy and seizures (116)
Headache (including migraine) (9)
Hydrocephalus (22)
Infection (neurology) (166)
Motor neurone disease (14)
Movement disorders (other than Parkinsons) (63)
Multiple sclerosis (19)
Muscle disease (40)
Neuroimaging (396)
Neurological injury (71)
Neuromuscular disease (77)
Neurooncology (116)
Neuroophthalmology (8)
Pain (neurology) (47)
Parkinson's disease (7)
Peripheral nerve disease (84)
Sleep disorders (neurology) (8)
Spinal cord (105)
Stroke (239)
Trauma CNS / PNS (40)
Variant Creutzfeld-Jakob Disease (2)
Neurology (1610)
Nursing (36)
Childhood nutrition (5)
Malnutrition (24)
Obesity (nutrition) (17)
Vitamins and supplements (46)
Nutrition and metabolism (118)
Obstetrics and gynaecology (590)
Oncology (1477)
Ophthalmology (765)
Orthopaedics (371)
Adolescent health
Bilirubin disorders (9)
Child abuse (6)
Child and adolescent psychiatry (paedatrics) (9)
Child health
Childhood nutrition (paediatrics) (7)
Congenital disorders (280)
Developmental paediatrics (4)
Failure to thrive (19)
Infant health (32)
Infant nutrition (including breastfeeding) (5)
Materno-fetal medicine (72)
Neonatal and paediatric intensive care (96)
Neonatal health (93)
Paediatrics (880)
End of life decisions (palliative care) (14)
Pain (palliative care) (8)
Palliative care (37)
Chemical pathology
Cytopathology
Histopathology
Inflammation
Microbiology
Molecular biology
Morbid anatomy / surgical pathology
Neuropathology
Pathology (572)
Drug misuse (including addiction) (33)
Medicines regulation
Toxicology (56)
Unwanted effects / adverse reactions (311)
Pharmacology and therapeutics (477)
Prison medicine (1)
Adjustment disorders
Alcohol-related disorders (4)
Anxiety disorders (including OCD and PTSD) (18)
Child and adolescent psychiatry (11)
Delirium (17)
Drugs misuse (including addiction) (27)
Drugs: psychiatry (29)
Eating disorders (7)
Impulse control disorders (6)
Memory disorders (psychiatry) (22)
Mood disorders (including depression) (33)
Personality disorders (2)
Psychiatry of old age (8)
Psychotherapy (14)
Psychotic disorders (incl schizophrenia) (37)
Sexual and gender disorders (2)
Sleep disorders (2)
Somatoform disorders (6)
Suicide (psychiatry) (7)
Psychiatry (221)
Radiology (873)
Continuing medical education
Disability (17)
Other rehabilitative therapies
Physiotherapy (41)
Rehabilitation medicine (84)
Acute renal failure (107)
Chronic renal failure (49)
Dialysis (61)
Fluid electrolyte and acid-base disturbances (78)
Nephrotic syndrome (29)
Proteinurea (29)
Renal transplantation (48)
Renal medicine (370)
Respiratory medicine (615)
Ankylosing spondylitis (2)
Biological agents (37)
Connective tissue disease (97)
Degenerative joint disease (9)
Drugs: musculoskeletal and joint diseases (26)
Fibromyalgia (2)
Musculoskeletal syndromes (71)
Osteoarthritis (13)
Osteoporosis (11)
Rheumatoid arthritis (40)
Sjogren's syndrome (3)
Systemic lupus erythematosus (60)
Vascularitis (161)
Rheumatology (570)
Sexual health (102)
Sports and exercise medicine (123)
Breast surgery (69)
Cardiothoracic surgery (205)
Gastrointestinal surgery (432)
General surgery (457)
Neurosurgery (204)
Oral and maxillofacial surgery (142)
Orthopaedic and trauma surgery (235)
Otolaryngology / ENT (246)
Plastic and reconstructive surgery (177)
Surgical oncology (230)
Transplantation (61)
Urological surgery (183)
Vascular surgery (192)
Surgery (2575)
Urology (273)
Communication
Clinical trials (epidemiology)
Epidemiologic studies
Population trends
Screening (epidemiology)
Survey techniques
Therapeutic trials
Time-to-event methods
Artificial and donated transplantation
Assisted dying
Clinical ethics
Codes of professional ethics
Competing interests (ethics)
Confidentiality
Drug issues
End of life decisions (ethics)
Ethics of abortion
Ethics of reproduction
Experiments in vivo
Informed consent
Research and publication ethics
Sexuality / gender
Ethics (16)
Ethnic studies (2)
Health economics (7)
Information management
Telemedicine
Health policy
Health service research
Journalology
Legal and forensic medicine
Choosing / changing career
Combining life and work
Continuous professional development
Flexible training
Getting and changing jobs
Getting and changing jobs (including job descriptions and contracts)
Leaving medicine
Medical careers
Organise and prepare your CV
Organise working abroad
Pay, working conditions, and health
Personal development
Portfolio development
Prepare for appraisal
Prepare for interview
Professional conduct and regulation
Professional regulation and standards
History taking and the physical examination
Postgraduate
Undergraduate
Medical education (108)
Doctors' morale and well being
Medical error/ patient safety
Quality improvement
Medical management (208)
Occupational and environmental medicine (141)
Abuse (child, partner, elder)
Air pollution
Drug misuse
Environmental issues
Health education
Health of indigenous peoples
Health promotion
Housing and health
Human rights
Obesity (public health) (5)
Screening (public health)
Sexual health (public health)
Social conditions and disease
Suicide (public health)
Urban health
Vaccination programs
Violence (other)
Violence against women
Public health (68)
Smoking and tobacco (16)
Sociology (1)
Comparative effectiveness research
Qualitative research
Quantitative research
Statistics and research methods (1)
10-Minute Consultation
Assessment of older adults
BMJ clinical evidence summaries
Care of older people
Change page
Clinical evidence
Clinical governance in primary care
Clinical guidelines (the theory)
Clinical Update
Competent novice
Complexity science
Conflict and health
Coping with loss
Data campaign
Diagnosis in general practice
Digital theme issue: Overdiagnosis
Drug points
E-cigarettes
Easily missed
Economics notes
Ethical debates
Evidence base of clinical diagnosis
Evidence based case report
Evidence based management of hypertension
Evidence based paediatrics
Extracts from BestTreatments
For and against (controversies in management)
Getting research findings into practice
Guideline summaries
Health needs assessment
How does it work?
If I ruled the NHS
Improving the quality of health care
Interactive case reports
Investigation
Lesson of the week
Making a difference
Managing demand
Maternal, child, and adolescent health
Measuring quality of life
Methods in health services research
Mid Staffordshire Inquiry
Modernising the NHS
Multimorbidity
Narrative based medicine
Non-communicable diseases
Patient authored
Patient journeys
Pharmacology
Practice pointer
Pregnancy plus
Primary care groups
Qualitative research in health care
Quality improvement report
Rapid Recommendation
Rational imaging
Rational testing
Regulating nursing homes
Research pointers
Safety alerts
Science, medicine, and the future
Scrap the Cap
Seven day NHS
Shared decision making
Spotlight on climate change
State of the Art
Statistics notes
Systematic reviews in health care
Teaching rounds
The BMJ Awards 2015
The World Bank and world health
Theories in health care and research
Therapeutics
Too much medicine
UK general election 2015
Uncertainties page
Understanding controlled trials
What the educators are saying
What your patient is thinking
What's new this month in BMJ Journals
When I use a word
Access to health care (9)
Adverse drug reactions and complications (328)
Corrections
Determinants of health (2)
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect (257)
Global health (71)
Health in vulnerable communities (12)
Images in... (2255)
Learning from errors (76)
Learning from unexpected outcome (positive or negative) (146)
Medical student electives
Medicine in the humanitarian sector
Myth exploded
New disease (44)
Novel diagnostic procedure (55)
Novel treatment (new drug/intervention; established drug/procedure in new situation) (393)
Other full case
Rare disease (2617)
Reminder of important clinical lesson (714)
Rural medicine
Unexpected outcome (positive or negative) including adverse drug reactions (219)
Unusual association of diseases/symptoms (708)
Unusual presentation of more common disease/injury (793)
Video reports
COVID-19 (548)
Editor's choice (66)
Anaesthetics and ITU
Anatomy quiz
Case report
Case Review
Case scenario
Drugs and therapeutics
Emergency medicine
Endocrinology
Gastroenterology
General practice
Haematology
Histopathology/cytology/pathology/autopsy
Infectious diseases
Law and ethics
Learning disabled
Obstetrics and gynaecology
onExamination questions
Ophthalmology
Orthopaedics and trauma
Paediatrics
Picture quiz
Renal medicine
Respiratory
Rheumatology
Spot Diagnosis
GUT Recent advances in clinical practice
GUT Snapshot
IP Cochrane corners
JCP Education
JECH Gallery
JMG Online mutation reports
Open access (795)
Animal Models
Biomarker Studies
Childhood Lupus
Clinical Trials and Drug Discovery
Co-morbidities
Cutaneous Lupus
Epidemiology and Outcomes
Immunology and Inflammation
Lupus Nephritis
Reproductive Health and APS
Quality Improvement Reports

Case Reports in Psychiatry

psychiatry research case reports indexing

Subject Area and Category

Psychiatry and Mental Health

Hindawi Limited

Publication type

2090682X, 20906838

Information

How to publish in this journal

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

Evolution of the percentage of female authors.

Evolution of the number of documents cited by public policy documents according to Overton database.

Evoution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

Name * Required

Email (will not be published) * Required

* Required Cancel

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Cookie settings

Cookie Policy

Legal Notice

Frontiers in Psychiatry
Adolescent and Young Adult Psychiatry
Research Topics

Case Reports in Adolescent and Young Adult Psychiatry

Total Downloads

Total Views and Downloads

About this Research Topic

Frontiers in Psychiatry is proud to present our Case Reports series. Our case reports aim to highlight unique cases of patients that present with an unexpected/unusual diagnosis, treatment outcome, or clinical course. Case reports provide insight into the differential diagnosis, decision making, and clinical ...

Keywords : Adolescent and Young Adult Psychiatry, Case Reports, Case Studies, Community Case Studies, #CollectionSeries

Important Note : All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Topic coordinators, recent articles, submission deadlines.

Submission closed.

Participating Journals

Total views.

Demographics

No records found

total views article views downloads topic views

Top countries

Top referring sites, about frontiers research topics.

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Case reports

Annals of General Psychiatry welcomes well-described reports of cases that include the following:

Unreported or unusual side effects or adverse interactions involving medications.
Unexpected or unusual presentations of a disease.
New associations or variations in disease processes.
Presentations, diagnoses and/or management of new and emerging diseases.
An unexpected association between diseases or symptoms.
An unexpected event in the course of observing or treating a patient.
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect.

Case reports submitted to Annals of General Psychiatry should make a contribution to medical knowledge and must have educational value or highlight the need for a change in clinical practice or diagnostic/prognostic approaches. The journal will not consider case reports describing preventive or therapeutic interventions, as these generally require stronger evidence.

Authors are encouraged to describe how the case report is rare or unusual as well as its educational and/or scientific merits in the covering letter that accompanies the submission of the manuscript.

Annals of General Psychiatry strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible. Please see Springer Nature’s information on recommended repositories .

Authors who need help depositing and curating data may wish to consider uploading their data to Springer Nature’s Research Data Support or contacting our Research Data Support Helpdesk . Springer Nature’s Research Data Support provides data deposition and curation to help authors follow good practice in sharing and archiving of research data, and can be accessed via an online form . The services provide secure and private submission of data files, which are curated and managed by the Springer Nature Research Data team for public release, in agreement with the submitting author. These services are provided in partnership with figshare. Checks are carried out as part of a submission screening process to ensure that researchers who should use a specific community-endorsed repository are advised of the best option for sharing and archiving their data. Use of Research Data Support is optional and does not imply or guarantee that a manuscript will be accepted.